AvevoRx Welcomes New Regional Director of Managed Care
Company’s latest senior-level position announced amidst a period of continuous, fast-paced growth and expansion for AvevoRx. Greensboro, N.C. – November 8, 2023 –AvevoRx, a national, independent provider of specialty infusion pharmacy services, has welcomed Denise Stechman as regional director of managed care. The senior-level position will see Ms. Stechman lead a robust payor-facing team charged […]
AvevoRx Experiences Dramatic Growth in First Half of 2023
Expansion into new markets and therapeutic categories, plus smart investments in systems and people, credited for driving advancement and setting the stage for future growth Greensboro, N.C. – October 1, 2023 – AvevoRx, a national, independent provider of specialty infusion pharmacy services, announced record growth in the first half of 2023. The company’s revenue and […]
AvevoRx Expands Coverage Area to Include Alabama, Michigan
The independent specialty infusion pharmacy is now licensed in 26 states, helping fuel its rapid growth and continued geographic expansion Greensboro, N.C. – September 28, 2023 – AvevoRx, a national, independent provider of specialty infusion pharmacy services, has announced its licensure in both Alabama and Michigan, adding to its nationwide geographic footprint. AvevoRx now holds […]
AvevoRx Signs Agreement for Subcutaneous Immunoglobulin Drug CUVITRU®
Deal announced amidst continuous, rapid growth and expansion for AvevoRx Greensboro, N.C. – September 14, 2023 – AvevoRx, a national, independent provider of specialty infusion pharmacy services, has signed an agreement with Cambridge, Mass.-based Takeda (TSE:4502/NYSE: TAK) to offer its subcutaneous immunoglobulin (Ig) drug CUVITRU to patients under its care. The signing is a notable […]
How Home Infusion Therapy Benefits Patients with Autoimmune Disorders
Living with an autoimmune disorder can be exhausting, especially during and in the aftermath of a pandemic. When you have this type of disease, the body’s immune system mistakenly attacks healthy cells. It can do that anywhere in the body and even in multiple areas, such as nerves, skin, muscles and bone. Fortunately, there are […]
AvevoRx Advances its Rapid Expansion Across U.S. to Offer Speciality Infusion Services in 24 States
A mix of organic growth and smaller, tuck-in acquisitions combine to outpace market. Greensboro, N.C. — July 12, 2023 — AvevoRx, an independent provider of specialty infusion pharmacy services, is now serving patients in 24 states, covering nearly 70 percent of the total U.S. population. The company, founded in Q3 2021 by a group of […]
AvevoRx Reaches Limited Distribution Agreement for Gammaplex® IG Treatment
Drug is the latest addition in the firm’s continued expansion of limited distribution offerings Greensboro, N.C. – June 16, 2023 – AvevoRx, a national, independent provider of specialty infusion pharmacy services, has announced a limited distribution agreement for Gammaplex®, an immune globulin (IG) product from Bio Products Laboratory (BPL). AvevoRx currently stocks Gammaplex and is […]
AvevoRx WELCOMES JENNIFER GEORGE AS DIRECTOR, ACUTE REVENUE CYCLE MANAGEMENT
Greensboro, N.C. – April 24, 2023 – AvevoRx, a national, independent provider of specialty infusion pharmacy services, announced today that Jennifer George joins the company as Director of Acute Revenue Cycle Management. Jennifer’s hire marks an important growth milestone for AvevoRX, which has been rapidly expanding its capabilities and national footprint to reach more customers in […]
AvevoRx CFO, Robin Johnson, Spends Time with Kentucky Students
Watch on Fox 56
AvevoRx ANNOUNCES ENTRY INTO ALPHA-1 PROTEINAISE INHIBITOR MARKET, INCREASING THERAPEUTIC ACCESS FOR PATIENTS WITH RARE FORM OF CONGENITAL EMPHYSEMA
“AvevoRx brings the knowledge and infrastructure to provide services and programs typically expected of much bigger pharmacies while leveraging our adaptability and commitment to delivering an extraordinarily customized, personal patient experience.” GREENSBORO, N.C. (PRWEB) January 27, 2023 AvevoRx, a national, independent provider of specialty infusion pharmacy services, has announced it will provide Alpha-1 proteinase inhibitor […]
AvevoRx ANNOUNCES ACQUISITION OF ACCESS TO CARE, LLC PHARMACY
Greensboro, N.C. – February 28, 2023 – AvevoRx, a national, independent provider of specialty infusion pharmacy services, has announced its acquisition of Access to Care, LLC, an independently-owned home infusion pharmacy based in Muncie, Indiana. Effective September 1, 2022, the acquisition expands access to acute home infusion therapies for patients across the Midwest region while […]
AvevoRX ENTERS BLEEDING DISORDERS MARKET WITH AN INFUSION PHARMACY PROGRAM TO SERVE PATIENTS WITH HEMOPHILIA & RELATED DISEASES
For this niche patient population, the program offers a refreshing solution to the lack of customizable, specialty pharmacy services currently available Greensboro, N.C. – December 6, 2022 – AvevoRx, a national, independent provider of specialty infusion pharmacy services, has announced the development of its new program to serve patient populations facing hemophilia and additional rare bleeding […]
AvevoRX NAMES PEG GRUENEMEIER DIRECTOR OF CLINICAL SERVICES & QUALITY
Infusion-industry nursing veteran joins the company as it forges rapid, national expansion AvevoRx, a national, independent provider of specialty infusion pharmacy services, has named Peg Gruenemeier, BSN, CRNI, IgCN, its director of clinical services and quality. In this role, Gruenemeier will lead the growth and expansion of AvevoRx’s nursing and quality departments – overseeing all […]
AvevoRx LAUNCHES NATIONWIDE SPECIALTY INFUSION PHARMACY SERVICE FOR PATIENTS FACING COMPLEX AND CHRONIC HEALTH DISORDERS
New venture focused on providing customized care with a personal touch A group of seasoned, specialty pharmacy and home infusion executives, with a combined 130 years of industry experience, have announced the formation of AvevoRx, a national, independent provider of specialty infusion pharmacy services. The venture brings bespoke services and clinical care to patients facing […]
